ArticleCaspian journal of internal medicine2025

Mesalazine vs. IBS-D: Examining its impact on patient symptoms & stool calprotectin levels: A randomized double-blind, placebo-controlled trial.

Mohammad Hossein Somi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.